Kangji Medical Holdings Limited (9997.HK)
HKD 6.52
(-1.21%)
HKD 6.52
(-1.21%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 419.61 Million | 319.31 Million | 435.74 Million | 221.04 Million | 325.84 Million | 204.73 Million |
| Net Income | 588.77 Million | 478.73 Million | 456.78 Million | 250.29 Million | 206.44 Million | 261.15 Million |
| Depreciation & Amortization | 32.95 Million | 21.41 Million | 11.78 Million | 8.17 Million | 6.81 Million | 6.26 Million |
| Deferred income taxes | - | 106.85 Million | 2.97 Million | 12.3 Million | - | - |
| Stock-based compensation | 8.62 Million | 10.96 Million | 8.28 Million | 18 Million | - | - |
| Change in working capital | -45.77 Million | -117.81 Million | -11.26 Million | -30.3 Million | -25.56 Million | -18.36 Million |
| Other non-cash items | -90.51 Million | -180.83 Million | -32.82 Million | -37.42 Million | 138.15 Million | -44.32 Million |
| Investing Cash Flow | -391.69 Million | -369.98 Million | -160.09 Million | -610.97 Million | 183.13 Million | -255.72 Million |
| Investments in PPE | -87.91 Million | -75.69 Million | -30.86 Million | -17.83 Million | -9.56 Million | -15.5 Million |
| Acquisitions | - | -19.82 Million | 158.82 Million | 607.25 Million | 10.77 Million | 4.45 Million |
| Investment purchases | -365.05 Million | -1.71 Billion | -5.75 Billion | -2.88 Billion | -1.11 Billion | -452.1 Million |
| Sales/Maturities of investments | 29.23 Million | 1.45 Billion | 5.59 Billion | 2.27 Billion | 1.1 Billion | 433 Million |
| Other Investing Activities | -304.87 Million | -17.48 Million | -129.22 Million | -593.14 Million | 192.69 Million | -225.59 Million |
| Financing Cash Flow | -243.53 Million | -472.79 Million | -97.61 Million | 2.15 Billion | -106.29 Million | -33 Thousand |
| Debt repayment | -10.6 Million | -9.2 Million | -1.49 Million | -194 Thousand | -21 Thousand | -31 Thousand |
| Dividends payments | -216.34 Million | -179.94 Million | -44.84 Million | -212.56 Million | -106.27 Million | - |
| Common Stock Repurchased | -16.58 Million | -281.76 Million | -51.07 Million | -402.29 Million | - | - |
| Common Stock Issuance | - | -110.15 Million | 52.56 Million | 2.85 Billion | - | - |
| Other Financing Activities | -1.00 | 108.27 Million | -52.76 Million | -91.46 Million | -106.29 Million | -2000.00 |
| Accounts receivables | -74.22 Million | -80.97 Million | 5.67 Million | -15.78 Million | -25.8 Million | -19.15 Million |
| Accounts payables | - | 28.31 Million | -27.62 Million | 2.21 Million | -11.66 Million | 19.15 Million |
| Inventory | 194 Thousand | -36.84 Million | -16.93 Million | -14.52 Million | 237 Thousand | -10.91 Million |
| Other working capital | 14.86 Million | -28.31 Million | 27.62 Million | -2.21 Million | 11.66 Million | -7.44 Million |
| Cash at beginning of period | 1.73 Billion | 2.17 Billion | 2.03 Billion | 469.33 Million | 64.58 Million | 110.8 Million |
| Cash at end of period | 1.52 Billion | 1.73 Billion | 2.17 Billion | 2.03 Billion | 469.33 Million | 64.58 Million |
| Capital Expenditure | -87.91 Million | -75.69 Million | -30.86 Million | -17.83 Million | -9.56 Million | -15.5 Million |
| Effect of forex changes on cash | -2.95 Million | 84.59 Million | -34.55 Million | -196.87 Million | 2.07 Million | 4.79 Million |
| Net cash flow / Change in cash | -218.56 Million | -438.87 Million | 143.49 Million | 1.56 Billion | 404.75 Million | -46.22 Million |
| Free Cash Flow | 331.69 Million | 243.61 Million | 404.88 Million | 203.21 Million | 316.27 Million | 189.23 Million |
| Breakdown | 2024 Q2 | 2023 FY | 2023 Q4 | 2023 Q2 | 2022 FY | 2022 Q4 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 285.84 Million | 588.77 Million | 248.56 Million | 255.46 Million | 478.73 Million | 321.02 Million |
| Depreciation & Amortization | 14.17 Million | 32.95 Million | 16.79 Million | 16.16 Million | 21.41 Million | 12.63 Million |
| Deferred income taxes | - | - | - | 7.72 Million | 106.85 Million | 52.12 Million |
| Stock-based compensation | 6.18 Million | 8.62 Million | 1.35 Million | 7.27 Million | 10.96 Million | 3.44 Million |
| Change in working capital | -1.34 Million | -45.77 Million | -26.77 Million | -32.39 Million | -117.81 Million | -55.55 Million |
| Other non-cash items | -83.13 Million | -90.51 Million | 10.13 Million | -76.95 Million | -180.83 Million | -90.97 Million |
| Investing Cash Flow | 1.21 Billion | -391.69 Million | 858.2 Million | -1.24 Billion | -369.98 Million | -18.12 Million |
| Investments in PPE | -35.3 Million | -87.91 Million | -63.2 Million | -23.61 Million | -75.69 Million | -45.25 Million |
| Acquisitions | - | - | - | - | -19.82 Million | - |
| Investment purchases | - | -365.05 Million | - | - | -1.71 Billion | - |
| Sales/Maturities of investments | - | 29.23 Million | - | - | 1.45 Billion | - |
| Other Investing Activities | 1.24 Billion | -304.87 Million | 921.4 Million | -1.22 Billion | -17.48 Million | 27.12 Million |
| Financing Cash Flow | -35.69 Million | -243.53 Million | -223.93 Million | -19.6 Million | -472.79 Million | -453.56 Million |
| Debt repayment | -4.88 Million | -10.6 Million | - | -4.71 Million | -9.2 Million | - |
| Dividends payments | - | -216.34 Million | -216.34 Million | - | -179.94 Million | -179.94 Million |
| Common Stock Repurchased | -30.8 Million | -16.58 Million | -2.87 Million | -13.7 Million | -281.76 Million | -268.7 Million |
| Common Stock Issuance | - | - | - | - | -110.15 Million | - |
| Other Financing Activities | - | -1.00 | -4.7 Million | -1.17 Million | 108.27 Million | -4.91 Million |
| Accounts receivables | 19.7 Million | -74.22 Million | -66.57 Million | -7.65 Million | -80.97 Million | -46.11 Million |
| Accounts payables | - | - | - | - | 28.31 Million | - |
| Inventory | -15.17 Million | 194 Thousand | 7.54 Million | -7.34 Million | -36.84 Million | -9.45 Million |
| Other working capital | -5.87 Million | 14.86 Million | 32.25 Million | -17.39 Million | -28.31 Million | 10 Thousand |
| Cash at beginning of period | 1.52 Billion | 1.73 Billion | 663.74 Million | 1.73 Billion | 2.17 Billion | 1.99 Billion |
| Cash at end of period | 2.91 Billion | 1.52 Billion | 1.52 Billion | 663.74 Million | 1.73 Billion | 1.73 Billion |
| Capital Expenditure | -35.3 Million | -87.91 Million | -63.2 Million | -23.61 Million | -75.69 Million | -45.25 Million |
| Effect of forex changes on cash | -4.06 Million | -2.95 Million | -27.68 Million | 24.73 Million | 84.59 Million | 26.05 Million |
| Net cash flow / Change in cash | 1.39 Billion | -218.56 Million | 856.65 Million | -1.07 Billion | -438.87 Million | -255.06 Million |
| Free Cash Flow | 186.42 Million | 331.69 Million | 186.86 Million | 145.93 Million | 243.61 Million | 145.31 Million |
ENX
115450
RIAS-B
6269
HAIS
6262